---
title: "The Nasdaq Biotechnology Index closed up more than 1.4%, outperforming the major U.S. stock indices"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264507456.md"
description: "The Nasdaq Biotechnology Index rose more than 1.4%, outperforming the broader U.S. stock market. Among the constituent stocks, Rigel Pharmaceuticals increased by 33.37%, Veracyte rose by 27.46%, Day One Biopharmaceuticals climbed by 25.21%, Fortrea Holdings gained 23.20%, and Sarepta Therapeutics was up 15.25%. Meanwhile, uniQure NV fell by 14.39%, Neurogene decreased by 14.75%, Larimar Therapeutics Inc. dropped by 15.26%, Compass Pathways declined by 17.19%, Supernus Pharmaceuticals was down 17.35%, and LENZ Therapeutics fell by 23.46%"
datetime: "2025-11-05T22:03:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264507456.md)
  - [en](https://longbridge.com/en/news/264507456.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264507456.md)
generator: "portal-rs"
---

# The Nasdaq Biotechnology Index closed up more than 1.4%, outperforming the major U.S. stock indices

Component stock Rigel Pharmaceuticals rose by 33.37%, Veracyte rose by 27.46%, Day One Biopharmaceuticals rose by 25.21%, Fortrea Holdings rose by 23.20%, and Sarepta Therapeutics rose by 15.25%. uniQure NV fell by 14.39%, Neurogene fell by 14.75%, Larimar Therapeutics Inc. fell by 15.26%, Compass Pathways fell by 17.19%, Supernus Pharmaceuticals fell by 17.35%, and LENZ Therapeutics fell by 23.46%

### Related Stocks

- [VCYT.US](https://longbridge.com/en/quote/VCYT.US.md)
- [DAWN.US](https://longbridge.com/en/quote/DAWN.US.md)

## Related News & Research

- [‘Open Your Eyes,’ Says Top Investor About Oracle Stock](https://longbridge.com/en/news/301160283.md)
- [Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.](https://longbridge.com/en/news/301114413.md)
- [Palantir vs. Oracle – Why Daniel Ives Says Buy One, Hold the Other](https://longbridge.com/en/news/301155464.md)
- [Broadcom's AI Revenue Is Growing at 221%. Here's Why Custom Chips Could Be a Bigger Business Than GPUs.](https://longbridge.com/en/news/301141333.md)
- [LIVE MARKETS-TSMC earnings could cause another round of consensus upgrades](https://longbridge.com/en/news/301145455.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**